Chlorinated hydrocarbons: estrogens and antiestrogens

Area of Science:

• Environmental Toxicology
• Endocrinology
• Cancer Biology

Background:

• 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds activate the aryl hydrocarbon (Ah) receptor, leading to various toxic effects.
• Ah receptor agonists are known to interfere with endocrine pathways, specifically inhibiting estrogen (E2)-induced responses in reproductive tissues and breast cancer cells.

Purpose of the Study:

• To investigate the complex interactions between TCDD- and E2-induced signaling pathways.
• To explore the potential of Ah receptor agonists as antiestrogenic and antitumorigenic agents for mammary cancer treatment.

Main Methods:

• Investigated the molecular mechanisms underlying the inhibition of estrogen signaling by Ah receptor agonists.
• Examined the role of 5'-flanking inhibitory-dioxin responsive elements (i-DREs) in mediating these inhibitory effects.
• Synthesized and evaluated novel alkyl polychlorinated dibenzofurans for their antiestrogenic and antitumorigenic properties.

Main Results:

• Demonstrated that TCDD and related compounds inhibit E2-induced responses in mammary and uterine tissues, as well as human breast cancer cell lines.
• Identified potential mechanisms involving i-DREs in target genes that contribute to the antiestrogenic effects.
• Developed a series of alkyl polychlorinated dibenzofurans with reduced toxicity and significant antiestrogenic and antitumorigenic activity.

Conclusions:

• Ah receptor agonists possess significant antiestrogenic and antitumorigenic activity relevant to mammary cancer.
• The development of less toxic analogs, such as alkyl polychlorinated dibenzofurans, offers promising therapeutic potential for mammary cancer treatment.